Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS

NCT00142987 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

664

Enrollment

INDUSTRY

Sponsor class

Conditions

IBS-C and IBS With Mixed Bowel Habits

Interventions

DRUG: Tegaserod

Sponsor

Novartis